US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist
  • 5.655
  • +0.445+8.54%
Close Nov 29 13:00 ET
  • 5.655
  • 0.0000.00%
Post 13:02 ET
241.81MMarket Cap-10098P/E (TTM)

DiaMedica Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
33.47%6.88M
18.92%5.64M
3.98%5.74M
51.90%21.27M
47.19%5.85M
64.87%5.16M
40.93%4.74M
56.14%5.52M
2.60%14M
22.40%3.97M
Selling and administrative expenses
0.80%1.9M
-22.20%1.71M
8.51%2.07M
32.38%8.16M
27.48%2.17M
26.68%1.89M
56.00%2.2M
21.83%1.9M
26.24%6.16M
23.85%1.7M
-General and administrative expense
0.80%1.9M
-22.20%1.71M
8.51%2.07M
32.38%8.16M
27.48%2.17M
26.68%1.89M
56.00%2.2M
21.83%1.9M
26.24%6.16M
23.85%1.7M
Research and development costs
52.29%4.98M
54.46%3.93M
1.60%3.68M
67.24%13.11M
61.98%3.68M
99.51%3.27M
30.08%2.54M
83.28%3.62M
-10.56%7.84M
21.33%2.27M
Operating profit
-33.47%-6.88M
-18.92%-5.64M
-3.98%-5.74M
-51.90%-21.27M
-47.19%-5.85M
-64.87%-5.16M
-40.93%-4.74M
-56.14%-5.52M
-2.60%-14M
-22.40%-3.97M
Net non-operating interest income expense
Other net income (expense)
-11.11%616K
94.10%526K
133.20%597K
446.46%1.93M
209.61%709K
811.84%693K
1,984.62%271K
631.43%256K
330.49%353K
3,171.43%229K
Other non- operating income (expenses)
-11.11%616K
94.10%526K
133.20%597K
446.46%1.93M
209.61%709K
811.84%693K
1,984.62%271K
631.43%256K
330.49%353K
3,171.43%229K
Income before tax
-40.39%-6.27M
-14.36%-5.11M
2.30%-5.14M
-41.69%-19.34M
-37.26%-5.14M
-46.26%-4.46M
-33.39%-4.47M
-50.39%-5.27M
-0.62%-13.65M
-15.59%-3.74M
Income tax
0.00%7K
0.00%7K
0.00%7K
53.57%43K
214.29%22K
0.00%7K
0.00%7K
0.00%7K
0.00%28K
0.00%7K
Net income
-40.33%-6.27M
-14.34%-5.12M
2.30%-5.15M
-41.72%-19.38M
-37.59%-5.16M
-46.16%-4.47M
-33.32%-4.48M
-50.29%-5.27M
-0.62%-13.68M
-15.56%-3.75M
Net income continuous Operations
-40.33%-6.27M
-14.34%-5.12M
2.30%-5.15M
-41.72%-19.38M
-37.59%-5.16M
-46.16%-4.47M
-33.32%-4.48M
-50.29%-5.27M
-0.62%-13.68M
-15.56%-3.75M
Minority interest income
Net income attributable to the parent company
-40.33%-6.27M
-14.34%-5.12M
2.30%-5.15M
-41.72%-19.38M
-37.59%-5.16M
-46.16%-4.47M
-33.32%-4.48M
-50.29%-5.27M
-0.62%-13.68M
-15.56%-3.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.33%-6.27M
-14.34%-5.12M
2.30%-5.15M
-41.72%-19.38M
-37.59%-5.16M
-46.16%-4.47M
-33.32%-4.48M
-50.29%-5.27M
-0.62%-13.68M
-15.56%-3.75M
Basic earnings per share
-25.00%-0.15
18.75%-0.13
30.00%-0.14
-15.38%-0.6
0.00%-0.14
0.00%-0.12
-23.08%-0.16
-53.85%-0.2
20.00%-0.52
-40.00%-0.14
Diluted earnings per share
-25.00%-0.15
18.75%-0.13
30.00%-0.14
-15.38%-0.6
0.00%-0.14
0.00%-0.12
-23.08%-0.16
-53.85%-0.2
20.00%-0.52
-40.00%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 33.47%6.88M18.92%5.64M3.98%5.74M51.90%21.27M47.19%5.85M64.87%5.16M40.93%4.74M56.14%5.52M2.60%14M22.40%3.97M
Selling and administrative expenses 0.80%1.9M-22.20%1.71M8.51%2.07M32.38%8.16M27.48%2.17M26.68%1.89M56.00%2.2M21.83%1.9M26.24%6.16M23.85%1.7M
-General and administrative expense 0.80%1.9M-22.20%1.71M8.51%2.07M32.38%8.16M27.48%2.17M26.68%1.89M56.00%2.2M21.83%1.9M26.24%6.16M23.85%1.7M
Research and development costs 52.29%4.98M54.46%3.93M1.60%3.68M67.24%13.11M61.98%3.68M99.51%3.27M30.08%2.54M83.28%3.62M-10.56%7.84M21.33%2.27M
Operating profit -33.47%-6.88M-18.92%-5.64M-3.98%-5.74M-51.90%-21.27M-47.19%-5.85M-64.87%-5.16M-40.93%-4.74M-56.14%-5.52M-2.60%-14M-22.40%-3.97M
Net non-operating interest income expense
Other net income (expense) -11.11%616K94.10%526K133.20%597K446.46%1.93M209.61%709K811.84%693K1,984.62%271K631.43%256K330.49%353K3,171.43%229K
Other non- operating income (expenses) -11.11%616K94.10%526K133.20%597K446.46%1.93M209.61%709K811.84%693K1,984.62%271K631.43%256K330.49%353K3,171.43%229K
Income before tax -40.39%-6.27M-14.36%-5.11M2.30%-5.14M-41.69%-19.34M-37.26%-5.14M-46.26%-4.46M-33.39%-4.47M-50.39%-5.27M-0.62%-13.65M-15.59%-3.74M
Income tax 0.00%7K0.00%7K0.00%7K53.57%43K214.29%22K0.00%7K0.00%7K0.00%7K0.00%28K0.00%7K
Net income -40.33%-6.27M-14.34%-5.12M2.30%-5.15M-41.72%-19.38M-37.59%-5.16M-46.16%-4.47M-33.32%-4.48M-50.29%-5.27M-0.62%-13.68M-15.56%-3.75M
Net income continuous Operations -40.33%-6.27M-14.34%-5.12M2.30%-5.15M-41.72%-19.38M-37.59%-5.16M-46.16%-4.47M-33.32%-4.48M-50.29%-5.27M-0.62%-13.68M-15.56%-3.75M
Minority interest income
Net income attributable to the parent company -40.33%-6.27M-14.34%-5.12M2.30%-5.15M-41.72%-19.38M-37.59%-5.16M-46.16%-4.47M-33.32%-4.48M-50.29%-5.27M-0.62%-13.68M-15.56%-3.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.33%-6.27M-14.34%-5.12M2.30%-5.15M-41.72%-19.38M-37.59%-5.16M-46.16%-4.47M-33.32%-4.48M-50.29%-5.27M-0.62%-13.68M-15.56%-3.75M
Basic earnings per share -25.00%-0.1518.75%-0.1330.00%-0.14-15.38%-0.60.00%-0.140.00%-0.12-23.08%-0.16-53.85%-0.220.00%-0.52-40.00%-0.14
Diluted earnings per share -25.00%-0.1518.75%-0.1330.00%-0.14-15.38%-0.60.00%-0.140.00%-0.12-23.08%-0.16-53.85%-0.220.00%-0.52-40.00%-0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data